BML Investment Partners, L.P. → Connect Biopharma Holdings Ltd CNTB

Stake: — Shares: — Class: Ordinary Shares, par value $0.000174 per Share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 1.00

3,499,648 shares short · +26.2% vs prior

Other 13D/G Filings on Connect Biopharma Holdings Ltd

Filed	Form	Filer	Stake	Shares
2026-04-01	SCHEDULE 13D/A	Panacea Innovation Ltd	21.20%	13,160,000	view →
2025-07-21	SCHEDULE	Panacea Innovation Ltd	25.10%	13,950,000	view →
2024-07-01	SC	Panacea Innovation Ltd	—	—	view →
2021-06-07	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →

Other Filings by BML Investment Partners, L.P.

Filed	Form	Issuer	Stake	Shares
2026-06-29	SCHEDULE 13G/A	ORAMED PHARMACEUTICALS INC. ORMP	—	—	view →
2025-03-05	SCHEDULE	Aadi Bioscience, Inc. WHWK	4.98%	2,435,000	view →
2025-02-24	SCHEDULE	Aadi Bioscience, Inc. WHWK	9.90%	2,435,000	view →
2025-02-04	SCHEDULE	Aadi Bioscience, Inc. WHWK	9.90%	2,435,000	view →
2024-01-11	SC	Forte Biosciences, Inc. FBRX	—	—	view →
2022-07-07	SC	Forte Biosciences, Inc. FBRX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →